
E31 - Next Frontier in Skin Cancer Care | Dr. Faisal Mehmud, Chief Medical Officer of Medicus Pharma
Episode 31
In this episode of the Life Science Insights Podcast , I'm delighted to welcome Dr. Faisal Mehmud, Chief Medical Officer of Medicus Pharma , a clinical-stage biotechnology company focused on developing innovative therapies for oncology and other high unmet medical needs.With an exceptional career spanning global pharmaceutical leaders including Sanofi, Novartis, Bristol Myers Squibb, Pfizer, and GSK , Dr. Mehmud shares his journey through clinical development, medical leadership, and drug innovation. We explore how Medicus Pharma is advancing novel therapeutic approaches for skin cancer and prostate cancer, and discuss the future of precision oncology, artificial intelligence, and patient-centered drug development.Our conversation highlights the company's lead programs, SkinJect and Teverelix , along with broader industry trends that are transforming clinical research, oncology, and the development of next-generation therapies.## Key Topics Discussed- Dr.
Publisher
Life Science Insights 360 Podcasts
Link
podcasters.spotify.com/pod/show/life-science-insights360/episodes/E31---Next-Frontier-in-Skin-Cancer-Care--Dr--Faisal-Mehmud--Chief-Medical-Officer-of-Medicus-Pharma-e3n97gq
Published
August 11, 2026
Duration
31 min
Format
Podcast
Category
Issues · Science
Source
RSS feed
Host
Life Science Insights360
Life Science Insights 360 Podcasts
@lifescienceinsights360podcas
#skincancercare #chiefmedicalofficer #medicuspharma #lifesciences
